Title: Classification of Eye Changes of Graves' Disease
Abstract: ThyroidVol. 2, No. 3 Classification of Eye Changes of Graves' DiseasePublished Online:30 Mar 2009https://doi.org/10.1089/thy.1992.2.235AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Classification of Eye Changes of Graves' Disease." , 2(3), pp. 235–236FiguresReferencesRelatedDetailsCited byRadiotherapy for Diseases of the Eye26 February 2020Role of a new bioassay for thyroid-stimulating antibodies (aequorin TSAb) in Graves’ ophthalmopathyEndocrine Journal, Vol. 67, No. 3Assessment of Orbital Computed Tomography (CT) Imaging Biomarkers in Patients with Thyroid Eye Disease13 June 2019 | Journal of Digital Imaging, Vol. 32, No. 6Early macular and peripapillary vasculature dropout in active thyroid eye disease23 August 2019 | Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, No. 11Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients4 April 2019 | Frontiers in Endocrinology, Vol. 10Vitamin D and Type I DiabetesThe Open Rheumatology Journal, Vol. 12, No. Suppl-1, M8Orbital decompression in thyroid eye diseaseOperative Techniques in Otolaryngology-Head and Neck Surgery, Vol. 29, No. 4Évaluation par questionnaires de l’amélioration de la qualité de vie des patients opérés de strabisme dans le cadre d’une maladie de BasedowJournal Français d'Ophtalmologie, Vol. 41, No. 9Imaging biomarkers in thyroid eye disease and their clinical associationsJournal of Medical Imaging, Vol. 5, No. 04Graves’ Ophthalmopathy31 May 2018Radiotherapy for the treatment of thyroid eye disease—a prospective comparison: Is orbital radiotherapy a suitable alternative to steroids?3 January 2017 | Irish Journal of Medical Science (1971 -), Vol. 186, No. 3Expression and clinical significance of connective tissue growth factor (CTGF) in Graves' ophthalmopathy19 August 2016 | British Journal of Ophthalmology, Vol. 101, No. 5Endocrine Myopathy and Orbitopathy26 May 2016Graves’ Ophthalmopathy1 February 2017Ophthalmic grading of facial paralysis: need for a closer look: Table 16 January 2015 | British Journal of Ophthalmology, Vol. 99, No. 9Some studies on the natural history of Graves' orbitopathy: increase in orbital fat is a rather late phenomenon3 July 2015 | European Journal of Endocrinology, Vol. 173, No. 2Double Vision Is a Major Manifestation in Moderate to Severe Graves' Orbitopathy, but It Correlates Negatively With Inflammatory Signs and ProptosisThe Journal of Clinical Endocrinology & Metabolism, Vol. 100, No. 5DEGRO practical guidelines for the radiotherapy of non-malignant disorders – Part IV9 December 2014 | Strahlentherapie und Onkologie, Vol. 191, No. 4Thyroid orbitopathy, an overview with special attention to the role of radiotherapyEndocrinología y Nutrición (English Edition), Vol. 62, No. 4Orbitopatía tiroidea, una visión global con atención especial al papel de la radioterapiaEndocrinología y Nutrición, Vol. 62, No. 4Characterization and Outcomes of Repeat Orbital Decompression for Thyroid-Associated Orbitopathy22 September 2014 | Orbit, Vol. 34, No. 2Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ OrbitopathyInternational Journal of Endocrinology, Vol. 2015Quality of Life in Graves’ OphthalmopathyPsychological Disturbances in Thyroid Eye Disease24 October 2014Methotrexate for the Treatment of Thyroid Eye DiseaseJournal of Ophthalmology, Vol. 2014Graves' Ophthalmopathy: Epidemiology and Natural HistoryInternal Medicine, Vol. 53, No. 5Thyroid orbitopathy9 January 2014 | Expert Review of Ophthalmology, Vol. 8, No. 2Thyroid Volume and Severity of Graves' Orbitopathy Maria Antonietta Profilo, Eleonora Sisti, Claudio Marcocci, Paolo Vitti, Aldo Pinchera, Marco Nardi, Roberto Rocchi, Francesco Latrofa, Francesca Menconi, Maria Antonietta Altea, Marenza Leo, Teresa Rago, and Michele Marinò4 January 2013 | Thyroid, Vol. 23, No. 1Quality of life in Graves’ ophthalmopathyBest Practice & Research Clinical Endocrinology & Metabolism, Vol. 26, No. 3Time course of Graves’ ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study16 November 2011 | Endocrine, Vol. 41, No. 2Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy9 December 2011 | Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 250, No. 3Determinants of Extraocular Muscle Volume in Patients with Graves' DiseaseJournal of Thyroid Research, Vol. 2012Low Dose Orbital Radiotherapy for Thyroid Eye Disease1 December 2011 | Orbit, Vol. 30, No. 6Association between radioiodine therapy for Graves’ hyperthyroidism and thyroid-associated ophthalmopathy20 April 2010 | International Ophthalmology, Vol. 30, No. 4The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves’ ophthalmopathy10 June 2010 | Acta Ophthalmologica, Vol. 88, No. 5Graves’ OphthalmopathyRisk Factors Associated with the Severity of Thyroid-Associated Orbitopathy in Korean PatientsKorean Journal of Ophthalmology, Vol. 24, No. 5Association studies of interleukin-8 gene in Graves’ disease and Graves’ ophthalmopathy9 October 2009 | Endocrine, Vol. 36, No. 3Thyroid Gland Testing8 March 2010Graves’ DiseaseAge Influences the Severity of Graves' Ophthalmopathy5 November 2008 | The Kaohsiung Journal of Medical Sciences, Vol. 24, No. 6Graves’ OrbitopathyApplication of digital infrared thermal imaging in determining inflammatory state and follow-up effect of methylprednisolone pulse therapy in patients with Graves’ ophthalmopathy26 July 2007 | Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 246, No. 199mTc-HYNIC-TOC scintigraphy in evaluation of active Graves’ ophthalmopathy (GO)20 July 2007 | Endocrine, Vol. 31, No. 3COX-2 and SCD, Markers of Inflammation and Adipogenesis, Are Related to Disease Activity in Graves' Ophthalmopathy Tereza Vondrichova, Annika de Capretz, Hemang Parikh, Christofer Frenander, Peter Åsman, Magnus Åberg, Leif Groop, Bengt Hallengren, and Mikael Lantz5 July 2007 | Thyroid, Vol. 17, No. 6A treatment strategy for Graves' orbitopathyNature Clinical Practice Endocrinology & Metabolism, Vol. 3, No. 5Effects of Total Thyroid Ablation Versus Near-Total Thyroidectomy Alone on Mild to Moderate Graves’ Orbitopathy Treated with Intravenous GlucocorticoidsThe Journal of Clinical Endocrinology & Metabolism, Vol. 92, No. 5Tratamiento de la oftalmopatía tiroideaEndocrinología y Nutrición, Vol. 53, No. 9VISA Classification for Graves OrbitopathyOphthalmic Plastic & Reconstructive Surgery, Vol. 22, No. 5Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers16 August 2006 | European Journal of Endocrinology, Vol. 155, No. 3Evaluation of the National Eye Institute Visual Function Questionnaire in Graves’ OphthalmopathyOphthalmology, Vol. 113, No. 8Clinical Evaluation of the Long-Term Response to Intravenous Pulses of Methylprednisolone in Patients With Moderate to Severe Graves OphthalmopathyThe Endocrinologist, Vol. 16, No. 4Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves’ disease1 June 2006 | Clinical and Experimental Immunology, Vol. 145, No. 1Slow-release lanreotide in Graves’ ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial11 March 2014 | Journal of Endocrinological Investigation, Vol. 29, No. 5Orbital decompression surgery for thyroid eye diseaseEuropean Journal of Anaesthesiology, Vol. 23, No. 3Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves’ ophthalmopathy treated successfully with glucocorticoids themselves18 March 2014 | Journal of Endocrinological Investigation, Vol. 28, No. 5The Clinicopathologic Basis of Graves' Ophthalmopathy: A Review18 January 2018 | European Journal of Ophthalmology, Vol. 15, No. 3VISA Classification for Thyroid-Related Orbitopathy9 April 2013Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathyClinical Endocrinology, Vol. 62, No. 1Pentoxifylline (PTX) - an Alternative Treatment in Graves' Ophthalmopathy (Inactive Phase): Assessment by a Disease Specific Quality of Life Questionnaire and by Exophthalmometry in a Prospective Randomized Trial18 January 2018 | European Journal of Ophthalmology, Vol. 14, No. 4Hipertiroidismo. Etiopatogenia. Clínica. Diagnóstico. TratamientoMedicine - Programa de Formación Médica Continuada Acreditado, Vol. 9, No. 14Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathyClinical Endocrinology, Vol. 60, No. 6Effects of Graves’ ophthalmopathy on quality of life18 March 2014 | Journal of Endocrinological Investigation, Vol. 27, No. 3Graves’ ophthalmopathy and atrophic thyroiditis: A case report27 March 2014 | Journal of Endocrinological Investigation, Vol. 27, No. 2Valoración y tratamiento de la oftalmopatía de GravesEndocrinología y Nutrición, Vol. 51, No. 2Ophthalmological evaluation in thyroid-associated ophthalmopathy26 September 2003 | Acta Ophthalmologica Scandinavica, Vol. 81, No. 5Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapyClinical Endocrinology, Vol. 59, No. 3La thyroïdectomie aggrave-t-elle l'ophtalmopathie basedowienne ?Annales de Chirurgie, Vol. 128, No. 2Orbital radiation therapy for Graves’ ophthalmopathy: Author replyOphthalmology, Vol. 110, No. 3Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 GyInternational Journal of Radiation Oncology*Biology*Physics, Vol. 55, No. 1The role of Tc-99m polyclonal human immunoglobulin G scintigraphy in Graves’ ophthalmopathyAnnals of Nuclear Medicine, Vol. 16, No. 7Current Medical Management of Graves OphthalmopathyOphthalmic Plastic & Reconstructive Surgery, Vol. 18, No. 6Prediction of the Progression of Thyroid-Associated Ophthalmopathy at First Ophthalmologic Examination: Use of a Neural Network Mario Salvi, Davide Dazzi, Isabella Pellistri, and Fabrizio Neri9 July 2004 | Thyroid, Vol. 12, No. 3Does smoking increase relapse rates in Graves’ disease?11 March 2014 | Journal of Endocrinological Investigation, Vol. 25, No. 2Factores pronósticos de recidiva, presentes en el momento del diagnóstico del hipertiroidismo en la enfermedad de Graves-Basedow tratada con antitiroideosEndocrinología y Nutrición, Vol. 49, No. 2Criterios terapéuticos en la oftalmopatía asociada a enfermedad tiroidea. Análisis en la comunidad andaluzaEndocrinología y Nutrición, Vol. 49, No. 8Serum Levels of Tumor Necrosis Factor-α, Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Cell Adhesion Molecule-1, and Soluble Interleukin-1 Receptor Antagonist in Patients with Thyroid Eye Disease Undergoing Treatment with Somatostatin Analogues G.E. Krassas, N. Pontikides, D. Doukidis, G. Heufelder, and A.E. Heufelder9 July 2004 | Thyroid, Vol. 11, No. 12Effect of 131Iodine Therapy on the Course of Graves' Ophthalmopathy: A Quantitative Analysis of Extraocular Muscle Volumes Using Orbital Magnetic Resonance Imaging M.K. Gupta, J. Perl, R. Beham, L.R. Sheeler, J.A. Foster, M. Gliga, N. McBride, M.R. Faiman, A.E. Mehta, R. Dattatreya, and C. Faiman9 July 2004 | Thyroid, Vol. 11, No. 10Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment20 December 2001 | Clinical Endocrinology, Vol. 55, No. 3Konservative Therapie bei endokriner Orbitopathie: "State of the Art"Acta Medica Austriaca, Vol. 28, No. 4Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves’ Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized StudyThe Journal of Clinical Endocrinology & Metabolism, Vol. 86, No. 8Radiotherapy for Graves’ OphthalmopathybThe Journal of Clinical Endocrinology & Metabolism, Vol. 86, No. 5High-dose intravenous corticosteroid therapy for Graves’ ophthalmopathy11 March 2014 | Journal of Endocrinological Investigation, Vol. 24, No. 3Quality of Life Measurement in Patients with Graves’ OphthalmopathyClinical Presentation and Natural History of Graves’ OphthalmopathyGraves' ophthalmopathy through the eyes of the patient: A state of the art on health-related quality of life assessment8 July 2009 | Orbit, Vol. 20, No. 4High-Dose Intravenous Pulse Therapy with Methylprednisolone and Orbital Irradiation in Graves’ OphthalmopathyThe Endocrinologist, Vol. 11, No. 1Somatostatin-Receptor Scintigraphy in Graves' Disease: Reproducibility and Variance of Orbital Activity G. J. Förster, F. Krummenauer, O. Nickel, and G. J. Kahaly29 January 2009 | Cancer Biotherapy & Radiopharmaceuticals, Vol. 15, No. 5The Prevalence and Clinical Significance of Blocking Thyrotropin Receptor Antibodies in Untreated Hyperthyroid Graves' Disease Won Bae Kim, Hyun Kyung Chung, Young Joo Park, Do Joon Park, Kazuo Tahara, Leonard D. Kohn, and Bo Youn Cho30 January 2009 | Thyroid, Vol. 10, No. 7AN EVIDENCE-BASED APPROACH TO THE TREATMENT OF GRAVES' OPHTHALMOPATHYEndocrinology and Metabolism Clinics of North America, Vol. 29, No. 2Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids24 December 2001 | Clinical Endocrinology, Vol. 52, No. 5Management of Graves’ Ophthalmopathy: Reality and Perspectives*7 November 2016 | Endocrine Reviews, Vol. 21, No. 2Cloning and Characterization of the Novel Thyroid and Eye Muscle Shared Protein G2s: Autoantibodies against G2s Are Closely Associated with Ophthalmopathy in Patients with Graves’ HyperthyroidismThe Journal of Clinical Endocrinology & Metabolism, Vol. 85, No. 4Assessment of disease severityRecommendations for the assessment of Therapeutic Outcome of Graves’ ophthalmopathy in clinical trialsLow- Versus High-Dose Radiotherapy for Graves’ Ophthalmopathy: A Randomized, Single Blind TrialThe Journal of Clinical Endocrinology & Metabolism, Vol. 85, No. 1The Combination of Absent Thyroid Peroxidase Antibodies and High Thyroid-Stimulating Immunoglobulin Levels in Graves' Disease Identifies a Group at Markedly Increased Risk of Ophthalmopathy D.H.C. KHOO, S.C. HO, L.L. SEAH, K.S. FONG, E.S. TAI, S.P. CHEE, P.H.K. ENG, S.E. AW, and A.C.K. FOK30 January 2009 | Thyroid, Vol. 9, No. 12Test-Retest Reliability of the GO-QOLJournal of Clinical Epidemiology, Vol. 52, No. 9Autoantibodies Reactive with Extracellular Matrix Proteins in Patients with Thyroid-Associated Ophthalmopathy TOMASZ BEDNARCZUK, CAROL STOLARSKI, ELIZA PAWLIK, MILENA SLON, MAREK ROWINSKI, SUMIHISA KUBOTA, YUJI HIROMATSU, ZBIGNIEW BARTOSZEWICZ, JACK R. WALL, and JANUSZ NAUMAN30 January 2009 | Thyroid, Vol. 9, No. 3Somatostatin Receptor Scintigraphy Before and After Treatment with Somatostatin Analogues in Patients with Thyroid Eye Disease G.E. KRASSAS, A. DOUMAS, TH. KALTSAS, A. HALKIAS, and N. PONTIKIDES30 January 2009 | Thyroid, Vol. 9, No. 1Thyroid-Associated Ophthalmopathy and DermopathyThyroid Eye Disease2 July 2009 | Seminars in Ophthalmology, Vol. 14, No. 2A 63 kDa Skeletal Muscle Protein Associated with Eye Muscle Inflammation in Graves' Disease is Identified as the Calcium Binding Protein Calsequestrin7 July 2009 | Autoimmunity, Vol. 29, No. 1Thyroid-Associated Ophthalmopathy in Black South African Patients with Graves' Disease: Relationship to Antiflavoprotein Antibodies BARRY JOFFE, KAZU GUNJI, VANESSA PANZ, MIKE ZOUVANIS, JIL SWANSON, BRIAN A.C. ACKRELL, and JACK R. WALL3 February 2009 | Thyroid, Vol. 8, No. 11Endokrine Orbitopathie: Vergleich der Langzeitergebnisse und Klassifikationen nach RadiotherapieStrahlentherapie und Onkologie, Vol. 174, No. 9Serological Reactivity of Recombinant 1D Autoantigen and Its Expression in Human Thyroid and Eye Muscle Tissue: A Possible Autoantigenic Link in Graves’ Patients1The Journal of Clinical Endocrinology & Metabolism, Vol. 83, No. 8The use of colour slides in the assessment of changes in soft-tissue involvement in Graves’ ophthalmopathy29 March 2014 | Journal of Endocrinological Investigation, Vol. 21, No. 7Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey4 January 2002 | Clinical Endocrinology, Vol. 49, No. 1Current management of thyroid-associated ophthalmopathy4 January 2002 | Clinical Endocrinology, Vol. 49, No. 1The Measurement of Change in Graves' Ophthalmopathy COLUM A. GORMAN9 June 2009 | Thyroid, Vol. 8, No. 6Endokrine Orbitopathie 1998Medizinische Klinik, Vol. 93, No. 6Clinical Presentation of Thyroid Associated Orbitopathy PAT KENDALL-TAYLOR and PETROS PERROS3 February 2009 | Thyroid, Vol. 8, No. 5Somatostatin Analogues in the Treatment of Thyroid Eye Disease G.E. KRASSAS3 February 2009 | Thyroid, Vol. 8, No. 5Role of Eye Muscle Antibody Measurement in Diagnosis of Thyroid-Associated Ophthalmopathy: A Laboratory UpdateEndocrine Practice, Vol. 4, No. 3Reevaluation of the Prevalences of Serum Autoantibodies Reactive with "64-kd Eye Muscle Proteins" in Patients with Thyroid-Associated Ophthalmopathy S. KUBOTA, K. GUNJI, C. STOLARSKI, J.S. KENNERDELL, and J. WALL9 June 2009 | Thyroid, Vol. 8, No. 2The 64-Kilodalton Eye Muscle Protein Is the Flavoprotein Subunit of Mitochondrial Succinate Dehydrogenase: The Corresponding Serum Antibodies Are Good Markers of an Immune-Mediated Damage to the Eye Muscle in Patients with Graves’ Hyperthyroidism1The Journal of Clinical Endocrinology & Metabolism, Vol. 83, No. 2T Cell Interactions with Extracellular Matrix Proteins in Patients with Thyroid-Associated Ophthalmopathy7 July 2009 | Autoimmunity, Vol. 27, No. 4Quality of Life in Patients with Graves' Ophthalmopathy is Markedly Decreased: Measurement by the Medical Outcomes Study Instrument M.N. GERDING, C.B. TERWEE, F.W. DEKKER, L. KOORNNEEF, M.F. PRUMMEL, and W.M. WIERSINGA3 February 2009 | Thyroid, Vol. 7, No. 6Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: Should Graves’ disease be considered a collagen disorder?27 March 2014 | Journal of Endocrinological Investigation, Vol. 20, No. 10Thyroid-Stimulating Antibody Assay Using a Human Thyrotropin Receptor Transfected Cell Line: Relationship to Clinical Features of Graves’ DiseaseEndocrine Practice, Vol. 3, No. 6Relationships of orbital computed tomographic findings and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalmopathy27 May 2009 | Acta Ophthalmologica Scandinavica, Vol. 75, No. 3A new approach to the study of Graves’ ophthalmopathy: standardized A-scan echography and octreotide scintigraphy as possible parameters for disease activityThe Effect of Somatostatin versus Corticosteroid in the Treatment of Graves' Ophthalmopathy ANNIE W.C. KUNG, JOHN MICHON, K.S. TAI, and F.L. CHAN4 February 2009 | Thyroid, Vol. 6, No. 5Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopathy2 April 2014 | Journal of Endocrinological Investigation, Vol. 19, No. 5Graves' hyperthyroidism, ophthalmopathy and pretibial myxedema may be components of a multi-system autoimmune disorder8 July 2009 | Orbit, Vol. 15, No. 3New imaging procedures in thyroid-associated ophthalmopathy8 July 2009 | Orbit, Vol. 15, No. 3Levels of manganese superoxide dismutase activity are increased in tears from patients with thyroid-associated ophthalmopathy8 July 2009 | Orbit, Vol. 15, No. 3MR T2 Relaxation Time for the Assessment of Retrobulbar Inflammation in Graves' Ophthalmopathy CHRISTA I. UTECH, UTA KHATIBNIA, PETER F. WINTER, and KLAUS G. WULLE4 February 2009 | Thyroid, Vol. 5, No. 3New Assays for the Measurement of Serum Antibodies Reactive with Eye Muscle Membrane Antigens Confirm Their Significance in Thyroid-Associated Ophthalmopathy A. BARSOUK, S. WENGROWICZ, D. SCALISE, C. STOLARSKI, V. NEBES, M. SATO, and J. R. WALL4 February 2009 | Thyroid, Vol. 5, No. 3Assessment and Management of the Patient with Graves’ OphthalmopathyEndocrine Practice, Vol. 1, No. 3Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathyInternational Journal of Radiation Oncology*Biology*Physics, Vol. 31, No. 3Thyroid-associated ophthalmopathy: pathogenesis and clinical managementBaillière's Clinical Endocrinology and Metabolism, Vol. 9, No. 1Natural history of thyroid associated ophthalmopathyClinical Endocrinology, Vol. 42, No. 1Conference Proceedings : “Progress in Thyroid-Associated Ophthalmopathy”7 July 2009 | Autoimmunity, Vol. 22, No. 3Measuring Eye Movements in Graves OphthalmopathyOphthalmology, Vol. 101, No. 8Plasma glycosaminoglycans in endocrine ophthalmopathy18 March 2014 | Journal of Endocrinological Investigation, Vol. 17, No. 1A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves' immunoglobulinsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, Vol. 1216, No. 3The Lancet, Vol. 342, No. 8877 Volume 2Issue 3Jan 1992 To cite this article:Classification of Eye Changes of Graves' Disease.Thyroid.Jan 1992.235-236.http://doi.org/10.1089/thy.1992.2.235Published in Volume: 2 Issue 3: March 30, 2009PDF download
Publication Year: 1992
Publication Date: 1992-01-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 145
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot